Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
REVA Medical Inc Company Overview 4
REVA Medical Inc Company Snapshot 4
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
REVA Medical Inc – Pipeline Analysis Overview 7
REVA Medical Inc – Key Facts 7
REVA Medical Inc – Major Products and Services 8
REVA Medical Inc Pipeline Products by Development Stage 9
REVA Medical Inc Ongoing Clinical Trials by Trial Status 11
REVA Medical Inc Pipeline Products Overview 13
Fantom Encore 13
Fantom Encore Product Overview 13
Fantom Encore – Broader Matrix 14
Fantom Encore – Broader Matrix Product Overview 14
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Clinical Trial 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Thinner Version 17
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Thinner Version Product Overview 17
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold 18
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold Product Overview 18
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold 19
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview 19
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold 20
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold Product Overview 20
REVA Medical Inc – Key Competitors 21
REVA Medical Inc – Key Employees 22
REVA Medical Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
REVA Medical Inc, Recent Developments 24
Nov 07, 2017: REVA Medical Reports Third Quarter 2017 Financial Results 24
Oct 31, 2017: New Fantom Data Demonstrates Safety at 2 Years 25
Oct 31, 2017: New Fantom Data Demonstrates Safety at 2 Years 26
Oct 23, 2017: REVA to Present Fantom 24-Month Data at TCT 2017 27
Oct 16, 2017: REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland 27
Oct 16, 2017: Fantom Bioresorbable Scaffold in Switzerland 28
Sep 20, 2017: Reva Announces Ray Larkin Jr. as Chairman of the Board of Directors 28
Sep 01, 2017: REVA Appoints Brandi Roberts as Chief Financial Officer and Company Secretary 28
Aug 10, 2017: REVA Medical: Half-Yearly Report 28
Aug 04, 2017: Boston Scientific’s Distribution Option Lapses 30
Appendix 31
Methodology 31
About GlobalData 33
Contact Us 33
Disclaimer 34
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
REVA Medical Inc Pipeline Products by Equipment Type 5
REVA Medical Inc Pipeline Products by Indication 6
REVA Medical Inc Ongoing Clinical Trials by Trial Status 6
REVA Medical Inc, Key Facts 7
REVA Medical Inc, Major Products and Services 8
REVA Medical Inc Number of Pipeline Products by Development Stage 9
REVA Medical Inc Pipeline Products Summary by Development Stage 10
REVA Medical Inc Ongoing Clinical Trials by Trial Status 11
REVA Medical Inc Ongoing Clinical Trials Summary 12
Fantom Encore - Product Status 13
Fantom Encore - Product Description 13
Fantom Encore - Broader Matrix - Product Status 14
Fantom Encore - Broader Matrix - Product Description 14
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety & Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Status 17
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Description 17
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Status 18
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Description 18
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status 19
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description 19
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status 20
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description 20
REVA Medical Inc, Key Employees 22
REVA Medical Inc, Subsidiaries 23
Glossary 32